Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC
瑞戈非尼联合口服甲氨蝶呤治疗既往接受过治疗的晚期KRAS突变型非小细胞肺癌的II期临床试验
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100741
Aredo, Jacqueline V; Wakelee, Heather A; Ramchandran, Kavitha J; Neal, Joel W; Diehn, Maximilian; Hui, Angela Bik-Yu; Salahudeen, Ameen; Kwong, Bernice; Berry, Gerald J; Guo, H Henry; Cunanan, Kristen; Vali, Shireen; Pancirer, Danny; Tsang, Vivian; Hwang, Grace; Loza, Monica; Johnson, Brittany; Blanchard, Isabelle; Padda, Sukhmani K